Molecular Diagnostics
World’s First AI-Powered Diagnostic Test Accurately Identifies Respiratory Viruses in Five Minutes
A world-first diagnostic test powered by AI that can identify known respiratory viruses within five minutes from just one nasal or throat swab could replace current testing methods which are limited to testing for just one infection or are either lab-based and time-consuming or fast and less accurate. More...09 Feb 2023
New Blood Test Detects Prostate Cancer With 94% Accuracy
Prostate cancer is the most common cancer in men, creating the need for a blood test that can detect it with greater accuracy. Now, new research shows that the (Prostate Screening EpiSwitch) ‘PSE’ blood test is 94% accurate and much superior than the currently used prostate-specific antigen (PSA) blood test. More...09 Feb 2023
World’s First Comprehensive Risk Test for Breast & Ovarian Cancer Launched
The world’s first comprehensive risk assessment test can evaluate a woman’s risk of developing breast and/or ovarian cancer either from a hereditary genetic mutation or from the far more common familial or sporadic cancer. Combined with other clinical risk factors, the test provides a comprehensive risk assessment in a simple saliva test. More...08 Feb 2023
New Assay Determines if Bladder Cancer Patients Need Radical Surgery
A new assay tested in patients with muscle-invasive bladder cancer immediately following treatment with a combination of the immune checkpoint inhibitors in the neoadjuvant setting has demonstrated clinical potential for helping oncologists determine whether or not the patients need to undergo radical surgery. More...08 Feb 2023
Urine Prostate Cancer Screening Test Offers Best-In-Class Accuracy and Stratified Risk Assessment
A non-invasive, data-driven, urine prostate cancer screening test can provide highly accurate, stratified risk assessment insights to guide clinical decisions for patients with elevated prostate-specific antigen (PSA) or abnormal digital rectal exam (DRE) findings. More...07 Feb 2023
Nanotechnology-Based Blood Test Could Revolutionize Prostate Cancer Diagnosis
Researchers have developed a new nanotechnology-based test that can detect and profile prostate cancers - even in microscopic amounts. The “liquid biopsy” test can help patients avoid unnecessary treatment-related side effects and direct them instead to effective therapies that could extend their life span. More...06 Feb 2023
New Device Detects Brain Tumors Using Urine
Researchers have used a new device to identify a key membrane protein in urine that indicates whether a person has a brain tumor. By using the protein to detect brain cancer, it will be possible to avoid invasive tests and increase the chances of the tumor being detected at an early enough stage for surgery. More...06 Feb 2023
Gold Member
Hematology Analyzer
Medonic M32B
Sample Transportation System
Tempus1800 Necto
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
In Other News
New Blood Test Could Ensure Timely Life-Saving Treatment of Heart Attack Victims
Real-Time PCR System Advances Large Reaction Volume IVD Assay Development and Diagnostic Testing
Focused-Ultrasound-Mediated Liquid Biopsy to Facilitate Diagnosis of Neurodegenerative Disorders
Blood Test Predicts Alzheimer's Risk 3.5 Years Before Clinical Diagnosis
Novel Biomarker-Based Tests to Predict Response to Drugs for Treatment of Chronic Kidney Disease
Newly Identified Protein Biomarkers in Blood Predict Sudden Cardiac Arrest Before it Strikes
Blood Test Identifies Osteoarthritis Progression More Accurately than Current Methods
New DNA Biosensor Could Make High-Quality Clinical Diagnostics More Accessible
New Technique Enables Measurement of Thousands of Molecules from Single Blood Drop
Non-Invasive Blood Test Helps Select Treatment for Advanced Gastrointestinal Stromal Tumors
Non-Invasive Melanoma Test Ushers in New Era in Skin Cancer Detection
World’s First Molecular, Cell-Based Test Offers Non-Surgical Method for Diagnosis and Staging of Endometriosis
Rapid POC Diagnostic Assay Could Detect and Measure Fentanyl Neutralizing Antibodies
Molecular Diagnostic Platform for Automated Sample Processing to Help Labs Achieve New Flexibility Level
Early Alzheimer’s Detection Sensor Could Also Diagnose Other Diseases at POC
First-Of-A-Kind Pan-Cancer Blood Test Could Predict Immunotherapy Efficacy and Toxicity
World’s First Test Detects Diabetics at Risk of Kidney Disease before Symptoms Appear
ELISAs Reliably Detect Anti-CCHFV Antibodies in Acute Infections
New Blood Test Tracks and Follows Neurodegeneration in Alzheimer's
Electrochemical Cell-Free Biosensor Directly Detects Influenza Antibodies in Blood at POC
Highly Accurate Test "Fishes" For Respiratory Viruses Using DNA as Bait
Cheap, Easy Blood Test Detects Cancer by Identifying Broken DNA
Simple Blood Test Could Screen for Common and Dangerous Pregnancy Complications
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.